Simon M. Carr

1.3k total citations
19 papers, 1.1k citations indexed

About

Simon M. Carr is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Simon M. Carr has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Simon M. Carr's work include Cancer-related gene regulation (13 papers), Epigenetics and DNA Methylation (12 papers) and RNA modifications and cancer (5 papers). Simon M. Carr is often cited by papers focused on Cancer-related gene regulation (13 papers), Epigenetics and DNA Methylation (12 papers) and RNA modifications and cancer (5 papers). Simon M. Carr collaborates with scholars based in United Kingdom, United States and Russia. Simon M. Carr's co-authors include Shonagh Munro, Nicholas B. La Thangue, N B La Thangue, Benedikt M. Kessler, Ervin Fodor, Frank T. Vreede, Geng Liu, Kanta Subbarao, Amber W. McCall and Udo Oppermann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The EMBO Journal.

In The Last Decade

Simon M. Carr

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon M. Carr United Kingdom 14 838 235 221 198 120 19 1.1k
Irina Dobromilskaya United States 9 431 0.5× 266 1.1× 131 0.6× 39 0.2× 86 0.7× 10 633
Meir Shamay United States 15 349 0.4× 436 1.9× 463 2.1× 114 0.6× 99 0.8× 31 912
Pradip Raychaudhuri United States 16 757 0.9× 487 2.1× 182 0.8× 119 0.6× 74 0.6× 21 1.1k
Shirine Benhenda France 9 934 1.1× 249 1.1× 329 1.5× 152 0.8× 93 0.8× 10 1.2k
Eugene Dempsey Ireland 15 318 0.4× 79 0.3× 140 0.6× 163 0.8× 119 1.0× 24 686
Franklin J. Nouvet United States 9 390 0.5× 114 0.5× 213 1.0× 209 1.1× 168 1.4× 12 853
Ian R. Kelsall United Kingdom 14 815 1.0× 225 1.0× 213 1.0× 403 2.0× 159 1.3× 16 1.1k
Mark A. Samols United States 10 604 0.7× 513 2.2× 356 1.6× 167 0.8× 584 4.9× 11 1.2k
Mi Li China 10 299 0.4× 77 0.3× 79 0.4× 275 1.4× 93 0.8× 19 522
Fulvia Cerruti Italy 13 586 0.7× 183 0.8× 131 0.6× 124 0.6× 32 0.3× 23 793

Countries citing papers authored by Simon M. Carr

Since Specialization
Citations

This map shows the geographic impact of Simon M. Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon M. Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon M. Carr more than expected).

Fields of papers citing papers by Simon M. Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon M. Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon M. Carr. The network helps show where Simon M. Carr may publish in the future.

Co-authorship network of co-authors of Simon M. Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Simon M. Carr. A scholar is included among the top collaborators of Simon M. Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon M. Carr. Simon M. Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bate-Eya, Laurel T., Simon M. Carr, Amit Shrestha, et al.. (2024). Sustained cancer‐relevant alternative RNA splicing events driven by PRMT5 in high‐risk neuroblastoma. Molecular Oncology. 19(3). 741–763. 1 indexed citations
2.
Barczak, Wojciech, Simon M. Carr, Geng Liu, et al.. (2023). Long non-coding RNA-derived peptides are immunogenic and drive a potent anti-tumour response. Nature Communications. 14(1). 1078–1078. 65 indexed citations
3.
Carr, Simon M., et al.. (2023). Citrullination and the protein code: crosstalk between post-translational modifications in cancer. Philosophical Transactions of the Royal Society B Biological Sciences. 378(1890). 20220243–20220243. 12 indexed citations
4.
Barczak, Wojciech, Jin Li, Simon M. Carr, et al.. (2020). PRMT5 promotes cancer cell migration and invasion through the E2F pathway. Cell Death and Disease. 11(7). 572–572. 31 indexed citations
5.
Carr, Simon M., Geng Liu, Wojciech Barczak, et al.. (2019). Arginine methylation expands the regulatory mechanisms and extends the genomic landscape under E2F control. Science Advances. 5(6). eaaw4640–eaaw4640. 24 indexed citations
6.
Carr, Simon M., Shonagh Munro, Cari A. Sagum, et al.. (2017). Tudor-domain protein PHF20L1 reads lysine methylated retinoblastoma tumour suppressor protein. Cell Death and Differentiation. 24(12). 2139–2149. 17 indexed citations
7.
Hookway, Edward S., Simon M. Carr, Rebecca Konietzny, et al.. (2017). Linker Histone H1.2 Directs Genome-wide Chromatin Association of the Retinoblastoma Tumor Suppressor Protein and Facilitates Its Function. Cell Reports. 19(11). 2193–2201. 9 indexed citations
8.
Lupberger, Joachim, Tom Croonenborghs, Philipp Mertins, et al.. (2017). Spatiotemporal functional genomics uncovers cell circuits triggering liver disease biology of hepatitis C virus infection. Journal of Hepatology. 66(1). S320–S320.
9.
Carr, Simon M., et al.. (2015). Post‐translational control of transcription factors: methylation ranks highly. FEBS Journal. 282(23). 4450–4465. 33 indexed citations
10.
Carr, Simon M., Shonagh Munro, Lykourgos‐Panagiotis Zalmas, et al.. (2014). Lysine methylation-dependent binding of 53BP1 to the pRb tumor suppressor. Proceedings of the National Academy of Sciences. 111(31). 11341–11346. 40 indexed citations
11.
Zheng, Shunsheng, Jutta Moehlenbrink, Yi-Chien Lu, et al.. (2013). Arginine Methylation-Dependent Reader-Writer Interplay Governs Growth Control by E2F-1. Molecular Cell. 52(1). 37–51. 117 indexed citations
12.
Zheng, Shunsheng, Shonagh Munro, Geng Liu, et al.. (2012). Arginine methylation controls growth regulation by E2F‐1. The EMBO Journal. 31(7). 1785–1797. 174 indexed citations
13.
Carr, Simon M., et al.. (2012). Diversity within the pRb pathway: is there a code of conduct?. Oncogene. 31(40). 4343–4352. 77 indexed citations
14.
Liu, Geng, et al.. (2012). NEDDylation regulates E2F‐1‐dependent transcription. EMBO Reports. 13(9). 811–818. 57 indexed citations
15.
Carr, Simon M., Shonagh Munro, & Nicholas B. La Thangue. (2012). Lysine methylation and the regulation of p53. Essays in Biochemistry. 52. 79–92. 11 indexed citations
16.
Carr, Simon M., Shonagh Munro, Benedikt M. Kessler, Udo Oppermann, & Nicholas B. La Thangue. (2010). Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein. The EMBO Journal. 30(2). 317–327. 86 indexed citations
17.
Munro, Shonagh, et al.. (2010). Lysine methylation regulates the pRb tumour suppressor protein. Oncogene. 29(16). 2357–2367. 94 indexed citations
19.
Carr, Simon M., Elena Carnero, Adolfo Garcı́a-Sastre, George G. Brownlee, & Ervin Fodor. (2005). Characterization of a mitochondrial-targeting signal in the PB2 protein of influenza viruses. Virology. 344(2). 492–508. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026